by Combat Cancer | Dec 6, 2024 | News
Bowel (colorectal) cancer is the third most common cancer worldwide, and the second biggest cause of cancer-related deaths. Despite this, it can be treated successfully if caught early. The annual “Decembeard” campaign was started by Bowel Cancer UK. This...
by Combat Cancer | Nov 29, 2024 | News
AI and Bladder Cancer Here in the beautiful, historic city of Vienna we are attending the BLADDR ’24 Global Forum, a highly interactive event where we are learning how to apply the latest 2024 evidence into clinical practice. The first session on Wednesday...
by Combat Cancer | Nov 22, 2024 | News
We previously wrote about age being a significant risk factor for the development of bladder cancer, and this article we will explore the many other risk factors. Bladder cancer is a complex disease with a variety of contributing factors. While age is often cited as a...
by Combat Cancer | Nov 16, 2024 | News
Cancer treatment has always been a challenging battlefield. But imagine if we could add a powerful weapon that enhances the efficacy of traditional methods like chemotherapy. That’s exactly what COMBAT Medical’s patented hyperthermic technologies are doing...
by Combat Cancer | Nov 2, 2024 | News
Pancreatic Cancer Awareness Month is an annual initiative in the UK which is designed to increase awareness and raise funding for the continued fight against one of the deadliest of cancers. This is a field we at Combat Medical are actively working in. The Combat PRS+...
by Combat Cancer | Oct 25, 2024 | News
Voided urine cytology (VUC) has been identified as a valuable tool in identifying the risk of non-muscle-invasive bladder cancer (NMIBC) before surgery. In a study published in Urologic Oncology: Seminars and Original Investigations, researchers Gómez del Cañizo and...
Recent Comments